相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
Juan F. Navarro-Gonzalez et al.
DIABETES CARE (2018)
Albumin downregulates Klotho in tubular cells
Beatriz Fernandez-Fernandez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis
Yin-ling Chen et al.
IMMUNOLOGY LETTERS (2017)
Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients
Sang Soo Kim et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease
P-C Wu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy
Huei-Fen Jheng et al.
DISEASE MODELS & MECHANISMS (2015)
Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis
Mao-Lu Tian et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)
Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase
Francisca Adilfa de Oliveira Garcia et al.
JOURNAL OF INFLAMMATION-LONDON (2015)
Inflammatory Cytokines in Diabetic Nephropathy
Javier Donate-Correa et al.
JOURNAL OF DIABETES RESEARCH (2015)
Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration
Carlamaria Zoja et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Dual Renin-Angiotensin System Blockade for Nephroprotection: Still under Scrutiny
Giorgio Gentile et al.
NEPHRON (2015)
Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes
Jian-Jun Liu et al.
ATHEROSCLEROSIS (2014)
The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin
Can Wu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
Ping-Min Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2014)
Effect of Add-on Pentoxifylline on Proteinuria in Membranous Glomerulonephritis: A 6-month Placebo-controlled Trial
Shirinsadat Badri et al.
CLINICAL DRUG INVESTIGATION (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial
Marian Goicoechea et al.
JOURNAL OF NEPHROLOGY (2012)
Pyridorin in Type 2 Diabetic Nephropathy
Edmund J. Lewis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
David K. Packham et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion
Osamu Asai et al.
KIDNEY INTERNATIONAL (2012)
DIABETES Treating diabetic nephropathy-still an unresolved issue
Mark E. Cooper
NATURE REVIEWS ENDOCRINOLOGY (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Klotho Depletion Contributes to Increased Inflammation in Kidney of the db/db Mouse Model of Diabetes via RelA (Serine)536 Phosphorylation
Yanhua Zhao et al.
DIABETES (2011)
Drug repositioning: Re-investigating existing drugs for new therapeutic indications
B. M. Padhy et al.
JOURNAL OF POSTGRADUATE MEDICINE (2011)
The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB
Juan A. Moreno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Avosentan for Overt Diabetic Nephropathy
Johannes F. E. Mann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Diabetic kidney disease: act now or pay later
Robert C. Atkins et al.
KIDNEY INTERNATIONAL (2010)
Effect of Pentoxifylline on GFR Decline in CKD: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial
Robert M. Perkins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
Kazunari Miyauchi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Klotho suppresses TNF-α-induced expression of adhesion molecules in the endothelium and attenuates NF-κB activation
Yoshihiro Maekawa et al.
ENDOCRINE (2009)
Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: A 12-month randomized trial
Shuei-Liong Lin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
The effect of pentoxifylline on proteinuria in diabetic kidney disease: A meta-analysis
Brendan B. McCormick et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease - A randomized placebo-controlled study
Juliano Lara Fernandes et al.
ATHEROSCLEROSIS (2008)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy
C. K. Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; Molecular evidence for involvement of oxidative stress
Pooneh Khoshakhlagh et al.
TOXICOLOGY MECHANISMS AND METHODS (2007)
Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients
Juan F. Navarro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Macrophage accumulation in human progressive diabetic nephropathy
Duy Nguyen et al.
NEPHROLOGY (2006)
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases
YM Chen et al.
KIDNEY INTERNATIONAL (2006)
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
C Lugnier
PHARMACOLOGY & THERAPEUTICS (2006)
Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration
Juan F. Navarro et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade:: A short-term, randomized, controlled trial
JF Navarro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
FY Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes
M Dalla Vestra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus
A Aminorroaya et al.
NEPHRON CLINICAL PRACTICE (2005)
Pentoxifylline suppresses renal tumour necrosis factor-α and ameliorates experimental crescentic glomerulonephritis in rats
YM Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat
ME Dávila-Esqueda et al.
EXPERIMENTAL DIABESITY RESEARCH (2004)
Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure
A Cooper et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
Dual regulation of tumor necrosis factor-α-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-κB and activator protein-1:: Modulation by type III phosphodiesterase inhibition
YM Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Pentoxifylline inhibits platelet-derived growth factor-stimulated cyclin D1 expression in mesangial cells by blocking Akt membrane translocation
SL Lin et al.
MOLECULAR PHARMACOLOGY (2003)
Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats
K Kalantarinia et al.
KIDNEY INTERNATIONAL (2003)
Progression to overt nephropathy in type 2 diabetes - The Casale Monferrato study
G Bruno et al.
DIABETES CARE (2003)
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus
JF Navarro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus:: Relationship with diabetic nephropathy
Y Moriwaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat
OME Abdel-Salam et al.
PHARMACOLOGICAL RESEARCH (2003)
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
K DiPetrillo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Effects of pentoxifylline, pentifylline and γ-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts
F Strutz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:: The Insulin Resistance Atherosclerosis Study
A Festa et al.
KIDNEY INTERNATIONAL (2000)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate
R Nosadini et al.
DIABETES (2000)
分享论文
